Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Cerebras Systems Inc. is a technology company specializing in hardware and systems for artificial intelligence workloads. Headquartered in Sunnyvale, California and founded in 2016, the company designs processors optimized for AI training and inference, targeting data centers, research institutions, and enterprises running large-scale machine learning models. Its portfolio includes AI supercomputers, purpose-built systems integrating compute, memory, and networking, as well as cloud-based access to its computing platforms. Cerebras Systems Inc. also provides AI model services that enable customers to run complex models without managing underlying infrastructure. By focusing on high-performance, domain-specific processors and tightly integrated systems, the company plays a role in accelerating computation for generative AI, natural language processing, and scientific computing. Its offerings support organizations that require efficient, large-scale AI processing beyond the capabilities of conventional general-purpose processors.
$168.52
$13.74 (-7.54%)
EOD Jun 25, 2026 · Twelve Data
The business is unprofitable at the operating level (-28.48% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 75.7% YoY with margins expanding 6.5pp. However, free cash flow softened 192%, worth monitoring whether this is timing or structural.
At 401x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 192% versus the prior year, cash generation momentum has weakened.
401.2x earnings. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$510M
▲ +75.7% YoY
Net Income (TTM)
$238M
▲ +149.4% YoY
Op. Margin
-28.48%
▲ +6.5pp YoY
ROIC
-93.27%
▲ +296.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$393M
▼ -191.7% YoY
Op. Cash Flow (TTM)
$346M
▼ -23.4% YoY
Net Debt
-$846M
Net Cash Position
Cash & Equiv.
$1.11B
3Y CAGR: +174.6%
Continue Research
At a P/E of 401.2, Cerebras Systems (CBRS)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Cerebras Systems scores 52/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Cerebras Systems scores 52 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a -28.5% operating margin and a -93.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh CBRS's valuation and scores 52/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.